EXTON, Pa., April 20, 2011 /PRNewswire/ — ViroPharma
Incorporated’s (Nasdaq:
VPHM) first quarter financial results for 2011 are expected to
be released on Thursday, April 28, 2011 before the open of the U.S.
financial markets.
The company will host a conference call and live audio webcast
at 9:00 a.m. Eastern Time on the same day. During the
conference call, ViroPharma management will discuss the 2011 first
quarter financial results and other business.
The press release and the live webcast of the conference call
will be accessible via ViroPharma’s corporate website at http://www.viropharma.com.
An audio archive will be available at the same address until
May 18, 2011. To participate in the conference call, please
dial (888) 299-4099 (domestic) and (302) 709-8337 (international).
After placing the call, please tell the operator you wish to
join the ViroPharma investor conference call.
About ViroPharma Incorporated
ViroPharma Incorporated is an international biopharmaceutical
company committed to developing and commercializing innovative
products for physician specialists to enable the support of
patients with serious diseases for which there is an unmet medical
need, and providing rewarding careers to employees.
ViroPharma commercializes Cinryze® (C1 esterase inhibitor
[human]) for routine prophylaxis against angioedema attacks in
adolescent and adult patients with hereditary angioedema (HAE).
ViroPharma commercializes Vancocin®, approved for oral
administration for treatment of antibiotic-associated
pseudomembranous colitis caused by Clostridium difficile and
enterocolitis caused by Staphylococcus aureus, including
methicillin-resistant strains (for prescribing information on
ViroPharma’s commercial products, please download the pack
‘/>”/>
